McKie PM, Cataliotti A, Huntley BK, Martin FL, Olson TM, Burnett JC (2009) A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions
J Am Coll Cardiol, 54 (11), 1024-32
PubMed 19729120 DOI 10.1016/j.jacc.2009.04.080
Boerrigter G, Costello-Boerrigter LC, Harty GJ, Huntley BK, Cataliotti A, Lapp H, Burnett JC (2009) B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity
Am J Physiol Regul Integr Comp Physiol, 296 (6), R1744-50
PubMed 19386989 DOI 10.1152/ajpregu.00059.2009
Chen HH, Cataliotti A, Schirger JA, Martin FL, Harstad LK, Burnett JC (2009) Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure
J Am Coll Cardiol, 53 (15), 1302-8
PubMed 19358945 DOI 10.1016/j.jacc.2009.01.030
Martin FL, Chen HH, Cataliotti A, Burnett JC (2008) B-type natriuretic peptide: beyond a diagnostic
Heart Fail Clin, 4 (4), 449-54
PubMed 18760756 DOI 10.1016/j.hfc.2008.03.011
Hawkridge AM, Muddiman DC, Hebulein DM, Cataliotti A, Burnett JC (2008) Effect of plasma protein depletion on BNP-32 recovery
Clin Chem, 54 (5), 933-4
PubMed 18443186 DOI 10.1373/clinchem.2007.098038
Martin FL, Chen HH, Cataliotti A, Burnett JC (2008) Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators
Rev Cardiovasc Med, 9 (1), 39-45
PubMed 18418308
Costello-Boerrigter LC, Boerrigter G, Harty GJ, Cataliotti A, Redfield MM, Burnett JC (2007) Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction
Hypertension, 50 (3), 481-8
PubMed 17635858 DOI 10.1161/HYPERTENSIONAHA.107.088534
Heublein DM, Huntley BK, Boerrigter G, Cataliotti A, Sandberg SM, Redfield MM, Burnett JC (2007) Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide
Hypertension, 49 (5), 1114-9
PubMed 17372040 DOI 10.1161/HYPERTENSIONAHA.106.081083
Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Lapp H, Stasch JP, Burnett JC (2007) Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure
Hypertension, 49 (5), 1128-33
PubMed 17325237 DOI 10.1161/HYPERTENSIONAHA.106.083832
Huntley BK, Sandberg SM, Noser JA, Cataliotti A, Redfield MM, Matsuda Y, Burnett JC (2006) BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors
J Cell Physiol, 209 (3), 943-9
PubMed 16986166 DOI 10.1002/jcp.20793